(Alliance News) - Celtic PLC on Friday reported a decline in profit for a first half that saw a "great deal of change and disruption", with the football club on its third manager of the season.

(Alliance News) - Dauch Corp on Friday reported a wider fourth quarter loss and a decline in annual profit, stemming from costs related to its buy of Dowlais.

The US delegation is being led by US Secretary of State Marco Rubio, who pointed to a "new era in geopolitics" before his arrival. The prime minister was seated next to Rubio at the Ukraine meeting, ...

ASLI is a London-based investor in logistics real estate, managed by Aberdeen Group PLC. Back in July 2024, its shareholders voted "overwhelmingly" for a managed wind-down after "extensive ...

The pound was quoted at USD1.3626 at the time of the London equities close on Friday, slightly down from USD1.3628 on Thursday. The euro stood at USD1.1868, almost flat against USD1.1869. Against the ...

(Alliance News) - Britain will spend GBP400 million developing long-range missiles this year as part of "a new deal for European security", the Defence secretary has announced. The money will go ...

Tern expects that dealings in open offer shares will start on March 4. The open offer is not underwritten. The proceeds of the offer will be used to participate in a short-term convertible loan note ...

NatWest also guided a return on tangible equity target for 2026 of greater than 17%. For 2028, it expects return on tangible equity of over 18%. At the bank's interims in July last year, it guided a ...

River Global separately on Friday confirmed it has presented an outline proposal for a reconstruction of European Opportunities that would include a full cash exit at close to net asset value.

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

(Alliance News) - SuperSeed Capital Ltd on Friday said its net asset value per share increased during the fourth quarter of 2025.

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall ...